Abstract:A low‐toxic aggregate of manganese‐based polyoxometalate single‐atom enzyme (Mn‐POM SAE) is constructed at neutral conditions. Specifically, Mn‐POM SAE nanospheres exhibit acid‐triggered nontoxicity‐to‐toxicity transition in acid tumor microenvironment (TME), upon degradation of larger Mn‐POM SAE into smaller toxic units of Mn(II)‐PW11. Therefore, the multienzyme‐mimicking (POD‐, OXD‐, CAT‐, and Gpx‐like) activity is initiated through single/double electron transfers for efficient and specific therapy. Single‐atom enzymes (SAzymes) exhibit great potential for chemodynamic therapy (CDT); while, general application is still challenged by their instability and unavoidable side effects during delivery. Herein, a manganese‐based polyoxometalate single‐atom enzyme (Mn‐POM SAE) is first introduced into tumor‐specific CDT, which exhibits tumor microenvironment (TME)‐activated transition of nontoxicity‐to‐toxicity. Different from traditional POM materials, the aggregates of low‐toxic Mn‐POM SAE nanospheres are obtained at neutral conditions, facilitating efficient delivery and avoiding toxicity problems in normal tissues. Under acid TME conditions, these nanospheres are degraded into smaller units of toxic Mn(II)‐PW11; thus, initiating cancer cell‐specific therapy. The released active units of Mn(II)‐PW11 exhibit excellent multienzyme‐like activities (including peroxidase (POD)‐like, oxidase (OXD)‐like, catalase (CAT)‐like, and glutathione peroxidase (Gpx)‐like activities) for the synergistic cancer therapy due to the stabilized high valence Mn species (MnIII/MnIV). As demonstrated by both intracellular evaluations and in vivo experiments, ROS is generated to cause damage to lysosome membranes, further facilitating acidification and impaired autophagy to enhance cancer therapy. This study provides a detailed investigation on the acid‐triggered releasing of active units and the electron transfer in multienzyme‐mimic‐like therapy, further enlarging the application of POMs from catalytical engineering into cancer therapy.

Coordination-Driven Self-Assembly Strategy-Activated Cu Single-Atom Nanozymes for Catalytic Tumor-Specific Therapy.

Ultrathin 2D Pd/Cu Single-Atom MOF Nanozyme to Synergistically Overcome Chemoresistance for Multienzyme Catalytic Cancer Therapy

Efficient bionic nanozyme based on AuPt NPs@ZIF-90 used for cyclic catalysis multimodal tumor therapy

Multi‐Enzyme Mimetic MoCu Dual‐Atom Nanozyme Triggering Oxidative Stress Cascade Amplification for High‐Efficiency Synergistic Cancer Therapy

Rapid Synthesis of Trimetallic Nanozyme for Sustainable Cascaded Catalytic Therapy via Tumor Microenvironment Remodulation

Dual Active Centers Linked by a Reversible Electron Station as a Multifunctional Nanozyme to Induce Synergetically Enhanced Cascade Catalysis for Tumor-Specific Therapy

Tumor-Microenvironment-Responsive Cascade Reactions by a Cobalt-Single-Atom Nanozyme for Synergistic Nanocatalytic Chemotherapy.

Ensemble of single-atom catalysis and defect engineering in Cu1/CeO2 nanozymes for tumor therapy

Coordination Self-Assembled AuTPyP-Cu Metal-Organic Framework Nanosheets with pH/Ultrasound Dual-Responsiveness for Synergistically Triggering Cuproptosis-Augmented Chemotherapy

Stimuli-Responsive Double Single-Atom Catalysts for Parallel Catalytic Therapy

Multiple therapeutic mechanisms of pyrrolic N-rich g-C3N4 nanosheets with enzyme-like function in the tumor microenvironment

Perovskite-structured Ultrasensitive CaMnO3 Nanoenzyme Enables Highly Efficient Ultrasound-Amplified and Catalysis-Involved Synergistic Tumor Therapy

Tumor microenvironment-activated single-atom platinum nanozyme with H2O2 self-supplement and O2-evolving for tumor-specific cascade catalysis chemodynamic and chemoradiotherapy

"Three‐in‐One" Nanozyme Composite for Augmented Cascade Catalytic Tumor Therapy

Multienzyme‐Like Polyoxometalate‐Based Single‐Atom Enzymes for Cancer‐Specific Therapy Through Acid‐Triggered Nontoxicity‐to‐Toxicity Transition

Engineering Atomically Dispersed Cu–N1S2 Sites via Chemical Vapor Deposition to Boost Enzyme‐Like Activity for Efficient Tumor Therapy

Biomimetic copper single-atom nanozyme system for self-enhanced nanocatalytic tumor therapy

In-situ activation of biomimetic single-site bioorthogonal nanozyme for tumor-specific combination therapy

Supramolecular amino acid-based metallo-nanozyme through multicomponent coordination self-assembly for in-site tumor synergistic catalytic-chemotherapy

Mn-doped single atom nanozyme composited Au for enhancing enzymatic and photothermal therapy

Ultrahigh density copper (I) single atom enzymes for tumor self-cascade catalytic therapy